 |
Dennis Slamon, MD
Hematology & Oncology
Male
English
Ronald Reagan UCLA Medical Center
UCLA Medical Center, Santa Monica
G39056
(310) 206-6909 Information and referral
(888) ONC-UCLA Information and appointments
(310) 825-5193 Administrative office
UCLA Oncology Center
200 UCLA Medical Plaza Suite 120
Los Angeles, CA 90095
Santa Monica
2020 Santa Monica Blvd, Suite 600
Santa Monica, CA 90404
Internal Medicine, American Board of Internal Medicine, 1978
Hematology-Oncology, UCLA School of Medicine, 1979 - 1982
Internal Medicine, University of Chicago Hospitals, 1976 - 1979
Internal Medicine, University of Chicago Hospitals, 1975 - 1976
MD, University of Chicago Pritzker School of Medicine, 1975
| Breast, Ovarian Cancer |
Chief, Hematology / Oncology
Director, Breast Cancer Program
Physician, Dumont-UCLA Liver Cancer Center, UCLA Santa Monica Hematology Oncology at 2020
Dennis J. Slamon, M.D., Ph.D., serves as director of Clinical/Translational Research, and as director of the Revlon/UCLA Women's Cancer Research Program at JCCC. He is a professor of medicine, chief of the Division of Hematology/Oncology and executive vice chair for research for UCLA's Department of Medicine. Slamon also serves as director of the medical advisory board for the National Colorectal Cancer Research Alliance, a fund-raising organization that promotes advances in colorectal cancer.
For 12 years, Dr. Slamon and his colleagues conducted the laboratory and clinical research that led to the development of the new breast cancer drug Herceptin, which targets a specific genetic alteration found in about 25 percent of breast cancer patients. To acknowledge Slamon's accomplishments, President Clinton appointed Slamon to the three-member President's Cancer Panel in June 2000.
A 1975 honors graduate of the University of Chicago's Pritzker School of Medicine, Slamon earned his Ph.D. in cell biology that same year. He completed his internship and residency at the University of Chicago Hospitals and Clinics, becoming chief resident in 1978. One year later, he became a fellow in the Division of Hematology/Oncology at UCLA.
Dr. Slamon has won nearly a dozen national research awards honoring his scientific endeavors.
In 2000, Slamon was awarded the Translational Medicine Award by the USCD-Salk Institute as well as the Bristol-Myers Squibb Oncology Millennium Award for significant achievement and leadership in breast cancer research.
In 2001, Slamon was awarded the Wadsworth Center's Brown-Hazen Award for Excellence in the Basic Sciences, and in 2002, he received the Jeffrey A. Gottlieb Memorial Award from the M.D. Anderson Cancer Center in Texas.
In 2003, Slamon received the Dorothy P. Landon-AACR Prize for Translational Cancer Research, an international award given by the Kirk A. and Dorothy P. Landon Foundation and the American Association for Cancer Research.
And in 2004, the American Cancer Society presented Slamon with the Medal of Honor, the top award bestowed by the organization.
Dr. Slamon received the Fifth Aultman Cancer Center Award from Kent State University and the David A. Karnofsky Memorial Award and Lecture at the American Society of Clinical Oncology honoring his work in the development of Herceptin, a molecularly targeted breast cancer therapy. He also received the Warren Alpert Foundation Scientific Prize and the 2007 Gairdner Foundation International Award for his work in the development of Herceptin.
UCLA Health System Publications
Physician Update : Summer 2007 - Oncology
Clinical Update: March 2007 - Surgical Oncology
Vital Signs Fall 2005: Breast Cancer Research Explores Promising Treatments
Our staff will assist you in selecting the appropriate UCLA clinical department for your patient.
Find out how to refer a patient
